An Act relative to patient access to biomarker testing to provide appropriate therapy

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 6 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 13%, measured from MA's completed sessions
Momentum +2 59/100 from the pace of recorded action
Time since last action -22 260 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.